Floatz logo

Therapeutic Asset Ratings

9,928 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Etoposide
Human T-Lymphotropic Virus 1 Infectious Disease
National Cancer Institute (NCI)P1CC (43)
Etoposide
Bladder Transitional Cell Carcinoma
Jonsson Comprehensive Cancer CenterP1CC (43)
Etoposide
Urethra Transitional Cell Carcinoma
Jonsson Comprehensive Cancer CenterP1CC (43)
Etoposide
Primary Brain Neoplasm
Theodore S. JohnsonP1CC (43)
Etoposide
Prostate Small Cell Carcinoma
Jonsson Comprehensive Cancer CenterP1CC (43)
Etoposide
Lymphoplasmacytic Lymphoma
City of Hope Medical CenterP1CC (43)
Etoposide
Urinary Bladder Cancer
Jonsson Comprehensive Cancer CenterP1CC (43)
Etoposide
Urethra Cancer
Jonsson Comprehensive Cancer CenterP1CC (43)
Etoposide
Stage IVb Bladder Cancer
Jonsson Comprehensive Cancer CenterP1CC (43)
Etoposide
Ureter Small Cell Carcinoma
Jonsson Comprehensive Cancer CenterP1CC (43)
Et-Stem
Frontotemporal Dementia
Samsung Medical CenterP1CC (43)
Everolimus
Amyotrophic Lateral Sclerosis Type 19
M.D. Anderson Cancer CenterP1CC (43)
evm14
Squamous Cell Lung Carcinoma
Everest Medicines (Beijing) Co., Ltd.P1CC (43)
Evolve104
Anal Squamous Cell Carcinoma
EvolveImmune United, IncP1CC (43)
Evolve104
Cervical Squamous Cell Carcinoma
EvolveImmune United, IncP1CC (43)
Evolve104
Skin Squamous Cell Carcinoma
EvolveImmune United, IncP1CC (43)
Evolve104
Squamous Cell Carcinoma Of Penis
EvolveImmune United, IncP1CC (43)
Evolve104
Squamous Cell Lung Carcinoma
EvolveImmune United, IncP1CC (43)
Evolve104
Urethra Squamous Cell Carcinoma
EvolveImmune United, IncP1CC (43)
Evolve104
Vulvar Squamous Cell Carcinoma
EvolveImmune United, IncP1CC (43)
Evuzamitide
Cryopyrin-Associated Periodic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID)P1CC (43)
Exemestane
Tuberous Sclerosis
SAPU NANO (US) LLCP1CC (43)
Exercise Mobilized Prophylactic Dli
Acute Lymphoblastic Leukemia
University of ArizonaP1CC (43)
Exercise Mobilized Prophylactic Dli
Acute Undifferentiated Leukemia
University of ArizonaP1CC (43)
exs73565
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.P1CC (43)
Showing 2001 to 2025 of 9,928 assets
PreviousPage 81 of 398Next